250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in Europe in November 2024

A list of 50 angel investors that invest in Life science startups based in Europe. We rank investors based on the number of investments they made in Life science companies from Europe. We update this investor list every month.

Top 50 Life Science Angel Investors in Europe in November 2024

Investor Life Science Europe investments
Jonathan Milner 8
Nadav Rosenberg 4
Stefano Bernardi 3
Andrew Keys 3
Carsten Maschmeyer 2
Luc Vauterin 2
Jan Hruska 2
Nico Wittenborn 2
Darrin Disley 2
Bradley Horowitz 2
Ian Hogarth 2
Mike Novogratz 2
Holger Hübner 2
Leena Niemistö 2
Jude Gomila 2
Albert Wenger 2
Robert Kopple 2
Pierre Drion 2
David Helgason 2
Nicholas Edwards 2
Thor Bjorgolfsson 2
Ed Parkinson 2
Sauli Törmälä 2
Mark Evans 2
Annie Vereecken 2
Griet Nuytinck 1
Virginie Saverys 1
Jens Mogensen 1
Mikael Lonn 1
Maximilien Levesque 1
Duncan Grierson 1
Ryan Bethencourt 1
Nadav Ben-Chanoch 1
Sharaf Yamani 1
Johnathan Matlock 1
Jon Oringer 1
Irwan Bello 1
Edward Lando 1
Mark Gillespie 1
Laura Iris Ferro 1
Jacques Lewiner 1
Bertrand Jacquelot 1
Sophia Bendz 1
Evren Ucok 1
Naheed Kurji 1
Toni Kroos 1
Mariliis Holm 1
Simon Galbraith 1
John Bethell 1
Balaji Srinivasan 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Canada
Portfolio highlights
  • Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.
  • LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
  • Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Nadav Rosenberg Angel · London, England, United Kingdom
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Pharmaceutical
  • Seed, Pre-Seed, Series A
  • United Kingdom, Israel, Singapore
Portfolio highlights
  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — With Loops causal insights you can identify your biggest opportunities to maximize your KPIs... try the Loops way
Stefano Bernardi Angel · San Francisco, California, United States
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more
Investment focus
  • Software, Biotechnology, Artificial Intelligence
  • Seed, Pre-Seed, Funding Round
  • Italy, France, Norway
Portfolio highlights
  • Freatic — Building the monetization layer for your alpha
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Andrew Keys Angel · 2 investments in the past 12 months
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more
Investment focus
  • Software, Finance, Blockchain
  • Seed, Pre-Seed, Series A
  • United States, India, Norway
Portfolio highlights
  • Stackr Labs — Micro-rollups to scale web3 applications
  • Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
  • Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Carsten Maschmeyer Angel · Hanover, Niedersachsen, Germany
Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Series A
  • Germany, Austria, Switzerland
Portfolio highlights
  • Zeedz — Gaming for a green future. Zeedz is a monster collectible game that targets real-world climate change. Discover a world of plantified magic, made in Berlin.
  • theblood — We are giving back self-determination, control and specific health conditions to our users through a non-invasive menstrual blood test
  • JobSwop.io — JobSwop.io is the employment software that allows you to find available positions but also filled ones for people looking to move jobs. The features of this app are Salary information, a Watch list, Area search, Integrated chat, Up to three Job profiles in one account, Document management.
Luc Vauterin Angel
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
  • Life Science, Data Integration, Data Visualization
  • Seed, Series A
  • Belgium
Portfolio highlights
  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Jan Hruska Angel
Jan Hruska
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Nico Wittenborn Angel · New York, New York, United States
Nico Wittenborn is an Investor at Adjacent.
Show more
Investment focus
  • Software, Health Care, Apps
  • Seed, Series A, Series B
  • United States, Germany, France
Portfolio highlights
  • Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Finally, a real solution for major gift fundraising. Powered by AI.
Darrin Disley Angel · Cambridge, Cambridgeshire, United Kingdom
Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.
Show more
Investment focus
  • Biotechnology, Health Care, Big Data
  • Seed, Series A, Funding Round
  • United Kingdom
Portfolio highlights
  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Bradley Horowitz Angel · Palo Alto, California, United States
Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • United States, United Kingdom, Germany
Portfolio highlights
  • Mill — Meet the cleanest, easiest way to prevent food waste at home. Mill recycles your peels, bones, stalks, and forgotten leftovers.
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • Overture Life — We are making In Vitro Fertilization (IVF) more accessible than ever before while improving success rates. An embryology lab in a box.
Ian Hogarth Angel · London, England, United Kingdom
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
  • Fabric — One home for everything. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files automatically gathered into one self-organizing home. Never forget anything again.
Mike Novogratz Angel · New York, New York, United States
Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.
Show more
Investment focus
  • Blockchain, Cryptocurrency, FinTech
  • Seed, Funding Round, Series B
  • United States, India, Germany
Portfolio highlights
  • Portal — The only custody-less interoperability protocol for Bitcoin. Swap native BTC, Ordinals, Runes with L2s and L1s
  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Holger Hübner Angel · Hamburg, Hamburg, Germany
Holger Hübner
Show more
Investment focus
  • B2B, SaaS, Audio
  • Seed, Pre-Seed
  • Germany
Portfolio highlights
  • musicube — Good music deserves to be found. That is why musicube develops revolutionary music search technology. Music streaming services and other companies can forward any user request to musicube and get back high quality data in real time (e.g. to return playlists etc.).
  • RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
  • HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Leena Niemistö Angel · Helsinki, Southern Finland, Finland
Leena Niemistö
Show more
Investment focus
  • Health Care, Software, E-Commerce
  • Seed, Funding Round, Pre-Seed
  • Finland, United States
Portfolio highlights
  • #Rens — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Jude Gomila Angel · San Francisco, California, United States · 2 investments in the past 12 months
Jude Gomila is currently CEO and Founder of the startup Golden.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Angel
  • United States, United Kingdom, Canada
Portfolio highlights
  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • HockeyStack — HockeyStack enables marketing teams to drive pipeline efficiently and sales teams to close deals faster with modern attribution, holistic buyer journeys, and account insights.
  • Farmako — Install Farmako app, get a free health ID and get all your medical records safe and secure in one place!
Albert Wenger Angel · New York, New York, United States
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more
Investment focus
  • Software, Analytics, Manufacturing
  • Series A, Series B, Seed
  • United States, Germany, Egypt
Portfolio highlights
  • Brale — Combining the best of CeFi & DeFi.
  • Terra.do — Learn about climate change and start working on climate change solutions today with the Terra.do community.
  • Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
Robert Kopple Angel · Los Angeles, California, United States
Robert Kopple
Show more
Investment focus
  • FinTech, Finance, Life Science
  • Funding Round, Convertible Note
  • United States, United Kingdom
Portfolio highlights
  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Pierre Drion Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Pierre Drion - CEO @ Petercam
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Series B, Funding Round
  • Belgium
Portfolio highlights
  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
David Helgason Angel · Copenhagen, Hovedstaden, Denmark
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more
Investment focus
  • Software, Gaming, Information Technology
  • Seed, Funding Round, Pre-Seed
  • United States, Denmark, Finland
Portfolio highlights
  • Isometric — Isometric is a carbon removal standard and registry.
  • Slope — We handle the lending, underwriting, debt collection and fully pay out to you immediately once the product or service ships.
  • Rocky Road — At Rocky Road, we are redefining social gaming with our social gaming network. We are hiring!
Nicholas Edwards Angel · Oxford, Oxfordshire, United Kingdom
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Seed, Funding Round
  • United Kingdom
Portfolio highlights
  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Thor Bjorgolfsson Angel · London, England, United Kingdom
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more
Investment focus
  • Big Data, TV, TV Production
  • Seed, Series A, Series C
  • United Kingdom, Germany
Portfolio highlights
  • Olvin — Olvin helps reactive real-world businesses get ahead of the curve and become proactive through the use of its AI powered, predictive analytics platform. Harnessing billions of real world data points, from events and precise location, through to weather and points of interest, Olvin's advanced neural network identifies patterns. Through theuse of both probabilistic and deterministic scoring, Olvin's AI provides actionable insights to brands, retailers and businesses to give them an unparalleled opportunity to delight their customers, identify opportunities and get ahead of potential threats.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • ATAI Life Sciences — ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Ed Parkinson Angel
Ed Parkinson
Show more
Investment focus
  • Software, Health Care, Life Science
  • Seed
  • United Kingdom
Portfolio highlights
  • Antiverse — Designing biologics for 100 challenging targets
Sauli Törmälä Angel · Helsinki, Southern Finland, Finland
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Finland
Portfolio highlights
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Mark Evans Angel · London, England, United Kingdom
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Series A, Seed, Series C
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • ONI — Where are you in your super-resolution journey? ONI is here to support you along your super-resolution journey Answer a few simple questions to discover key resources that can help you make the most of single-molecule imaging technology across a wide range of applications Products Gallery FAQs Subscribe to our mailing list
  • Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Annie Vereecken Angel
Annie Vereecken
Show more
Investment focus
  • Biotechnology, Medical, Hospital
  • Seed, Series A, Funding Round
  • Belgium
Portfolio highlights
  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Griet Nuytinck Angel
Griet Nuytinck is founder of Anacura.
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium
Portfolio highlights
  • 4Tissue — Shaping the Future of Regenerative Medicine
Virginie Saverys Angel
Virginie Saverys is a entrepreneur.
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium
Portfolio highlights
  • 4Tissue — Shaping the Future of Regenerative Medicine
Jens Mogensen Angel
Jens Mogensen is an Angel Investor.
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Series A
  • Sweden
Portfolio highlights
  • Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Mikael Lonn Angel
Mikael Lonn is an Angel Investor.
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Series A
  • Sweden
Portfolio highlights
  • Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Maximilien Levesque Angel · Paris, Ile-de-France, France
Maximilien Levesque - CEO and co-founder @ AQEMIA
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • United Kingdom
Portfolio highlights
  • CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Duncan Grierson Angel
Duncan Grierson
Show more
Investment focus
  • Water, Medical, CleanTech
  • Seed, Series A
  • United Kingdom
Portfolio highlights
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
  • Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
Ryan Bethencourt Angel · San Francisco, California, United States
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more
Investment focus
  • Biotechnology, Food Processing, Food and Beverage
  • Pre-Seed, Seed, Angel
  • United States, Chile, India
Portfolio highlights
  • WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Nadav Ben-Chanoch Angel · Miami, Florida, United States
Nadav Ben-Chanoch - Partner @ Pareto Holdings
Show more
Investment focus
  • Software, FinTech, Information Technology
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
Sharaf Yamani Angel · London, England, United Kingdom
Sharaf Yamani - Managing Director @ Windlesham Advisors
Show more
Investment focus
  • Biotechnology, Software, Life Science
  • Seed
  • India, United Kingdom
Portfolio highlights
  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Johnathan Matlock Angel · Bedford, Bedfordshire, United Kingdom
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Pre-Seed
  • United Kingdom
Portfolio highlights
  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
  • Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Jon Oringer Angel · Miami, Florida, United States · 2 investments in the past 12 months
Jon Oringer is the founder and chairman of Shutterstock.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Funding Round
  • United States, France, United Kingdom
Portfolio highlights
  • SLUSHY — SLUSHY is a secure mobile web based platform for content creators to find, grow, & monetize their audiences. A creator first, tech-driven tool, designed with key discoverability features and audience insights. In a market where existing solutions (OnlyFans, Patreon) fall short of their creators' demands, SLUSHY provides an alternativesolution for professional content creators that prioritizes their monetization, support and management needs. SLUSHY incorporates a powerful legal framework, with robust compliance tools including simplified consent, ID verification, and content moderation. The new home of unrestricted content, SLUSHY is here.
  • Skedway — The optimization hub for the Modern Enterprise - Visualize, integrate and manage every shared company asset in one place.
  • Unsloth AI — Easy finetuning for AI and LLMs. Open-source and for beginners. Get faster with Unsloth.
Irwan Bello Angel · San Francisco, California, United States · 3 investments in the past 12 months
Irwan Bello is an individual investor.
Show more
Investment focus
  • Information Technology, Internet, Life Science
  • Seed, Pre-Seed
  • France, United States
Portfolio highlights
  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
  • Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
  • Twin — We are building the AI productivity platform for SMB teams to automate complex and repetitive tasks across, as seamlessly as delegating them to smart interns.
Edward Lando Angel · San Francisco, California, United States · 5 investments in the past 12 months
Edward Lando is the Founder of Pareto Holdings. He previously worked at Horizons School of Technology as a Co-Founder. Edward Lando attended the Wharton School.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • SiPay — Sipay is a next-generation financial technology company offering a comprehensive all-in-one financial services platform. It enables B2B, B2C, and Sipay as a Service (Embedded Finance) customers to address all their banking and financial needs without requiring any other partners.
  • Syntetica — Syntetica is a nylon recycling startup that addresses pollution in the fashion industry by transforming discarded nylon products into high-quality, reusable materials. Their innovative processes help reduce waste, conserve resources, and promote sustainability within the fashion sector.
  • Unicorn Auctions — Unicorn Auctions offers rare spirits auctions to buyers, sellers, and collectors. They provide ios and android apps in addition to their web bidding platform for digital auctions. To ensure examination of every asset listed, they must take physical possession of their items.
Mark Gillespie Angel · Los Angeles, California, United States
Recently named as one of Billboard’s 2021 Change Agents, as well as one of the World's Greatest Managers by Music Business Worldwide, Mark Gillespie is a world-class British CEO, manager, and producer whose vision and drive have led him to build Three Six Zero into the global entertainment powerhouse that it is today. Widely recognized as oneof the industry's preeminent executives, Gillespie has been instrumental in guiding the careers of Frank Ocean and Calvin Harris, most recently closing a deal in excess of $100MM for his publishing catalogue. With offices in Los Angeles, Miami, and London, Gillespie provides the leadership necessary to ensure that Three Six Zero and its clients remain at the forefront of the music, film, television, and digital content landscapeFueled by a lifelong passion for music, Gillespie launched his career in his hometown of Birmingham, UK, where he proved to be an invaluable asset for superclub Godskitchen. Since then, he has established himself as a visionary in the entertainment industry, having worked in partnerships with Sony Music Entertainment, Jay-Z and Roc Nation, and most recently Westbrook Entertainment, whose talent roster includes Will Smith, Jada Pinkett Smith, and the entire Smith Family.A relentless pioneer and entrepreneur, Gillespie has joined forces with Pete Tong MBE to run Three Six Zero Recordings, his own in-house record label, while continuing to expand an already successful presence in film and television. Along with several other projects in the pipeline, the company's first feature film – prestige drama, VOX LUX – starring Natalie Portman and Jude Law, including an original soundtrack by Sia, was released in 2018.With a passion for innovation at the intersection of media, technology, and apparel, Gillespie has invested in companies such as Outdoor Voices, Stance, Ember Technologies, Stem Disintermedia, and Saavn. Committed to giving back and continuously fostering artistic talent, Gillespie has also remained a longtime philanthropist and advocate, sitting on both the Music Committee of Children in Conflict and the core screening panel of the Recording Academy. In his downtime, Gillespie enjoys following Manchester United and is an avid collector of modern art.
Show more
Investment focus
  • Music, Internet, Video
  • Funding Round, Seed, Series B
  • United States, United Kingdom, India
Portfolio highlights
  • Bkstg — Bkstg was founded by tech and music entrepreneurs to reinvent the way artists and fans connect by creating a new form of direct relationship that’s never existed before.
  • Hyperice — HyperIce is a recovery and movement enhancement technology company specializing in vibration, percussion, and thermal technology. Its technology is used by the athletes in professional and collegiate training rooms and fitness facilities globally.The company is driven by a mission to provide everyone with the innovative technology in acceleratingrecovery time, preventing injury, and enhancing the body’s ability to move efficiently. HyperIce was founded in 2010 by Anthony Katz.
  • Biosceptre — A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from
Laura Iris Ferro Angel · Milan, Lombardia, Italy
Laura Iris Ferro
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Pre-Seed, Funding Round
  • Italy
Portfolio highlights
  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
Jacques Lewiner Angel
Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Series C
  • France
Portfolio highlights
  • Cytoo — CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening.They develop, manufacture, and distribute products that make cellular analysis robust and reliable by dramatically decreasing cell variability.There new micropattern-based products aredesigned to meet the needs of all clients whatever their research goals. They are open to suggestions or specific requests that can improve and spread the scope of this breakthrough in quantitative cell analysis.
  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Bertrand Jacquelot Angel · Paris, Ile-de-France, France
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more
Investment focus
  • E-Commerce, Information Technology, Food and Beverage
  • Pre-Seed, Seed, Angel
  • France, United States
Portfolio highlights
  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Sophia Bendz Angel · Stockholm, Stockholms Lan, Sweden
Sophia Bendz - Partner @ Cherry Ventures
Show more
Investment focus
  • Health Care, Software, Apps
  • Seed, Pre-Seed, Funding Round
  • Sweden, United Kingdom, United States
Portfolio highlights
  • mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
  • Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
  • Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Evren Ucok Angel · Istanbul, Istanbul, Turkey
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
  • Medical, Health Care, Life Science
  • Series A
  • Turkey, Belgium
Portfolio highlights
  • idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Naheed Kurji Angel · Toronto, Ontario, Canada
Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica provides the pharmaceutical industry with an integrated, holistic, and end-to-end enabling platform that enhances how scientists design, screen,and personalize medicines for patients, and has recently been named by Deep Knowledge Analytics as one of the top 20 AI in Pharma companies globally. Naheed is passionate about how people interact with technology to make more informed and faster decisions, and is dedicated to advancing the responsible application of AI to healthcare problems. At Cyclica, he focuses on strategy and corporate development activities to affect change in the pharmaceutical industry, and strives to foster an environment where his team can solve the biggest challenges in human health through groundbreaking innovation. Naheed is a co-founder of The Alliance for Artificial Intelligence in Healthcare (AAIH), of which Naheed is 1 of 4 appointed Executive Officers. Naheed is an experienced professional specialized in strategic planning, corporate finance and entrepreneurship, having received an MBA from the University of Toronto, Rotman School of Management, and a Certificate from MIT on Artificial Intelligence and the Implication on Business Strategy. He has been featured in the Globe and Mail, CBC, Forbes, Vanity Fair, StartUp Health Magazine, WuXi Insider Perspective, and VentureBeat. Naheed is also a guest lecturer at various universities globally on the topic of entrepreneurship and AI in medicine.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • United Kingdom
Portfolio highlights
  • CardiaTec Biosciences — CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery to deliver the next generation of therapeutics
Toni Kroos Angel
Toni Kroos is a German professional footballer who plays as a midfielder for La Liga club Real Madrid.
Show more
Investment focus
  • Health Care, Rental, Fitness
  • Seed, Pre-Seed, Funding Round
  • Germany
Portfolio highlights
  • DUKE — Duke is a technology company that operates a real time car logistics system. Our Mission is to provide an insane customer experience for car rental. Duke offers on demand rental cars through a 24/7 delivery service.
  • rebirth:active — rebirth: active is an evidence-based, individual health solution that provides your employees with the tools they need to improve their overall health and well-being.
  • HMNC Brain Health — HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.
Mariliis Holm Angel · Research Triangle, North Carolina, United States
I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.
Show more
Investment focus
  • Food Processing, Seafood, Wellness
  • Pre-Seed, Angel
  • Spain, Iceland, United States
Portfolio highlights
  • Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Simon Galbraith Angel · Cambridge, Cambridgeshire, United Kingdom
Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
Show more
Investment focus
  • Software, Health Care, Life Science
  • Pre-Seed, Funding Round
  • Croatia, United Kingdom
Portfolio highlights
  • BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
  • SysKit — Syskit is a software development company specialized in enterprise tools for Microsoft 365, SharePoint, Windows Server, Remote Desktop Services, Citrix.
John Bethell Angel · Barcelona, Catalonia, Spain
Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.
Show more
Investment focus
  • FinTech, Medical, Life Science
  • Debt Financing
  • Spain
Portfolio highlights
  • Capital Cell — Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.
Balaji Srinivasan Angel · San Francisco Bay Area, California, United States · 31 investments in the past 12 months
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more
Investment focus
  • Blockchain, Cryptocurrency, Software
  • Seed, Series A, Pre-Seed
  • United States, India, Singapore
Portfolio highlights
  • ZAR — Enjoy borderless banking with a USD Visa card powered by stablecoins. Available in 180+ countries. Sign up for your account today!
  • The Arena — Arena. social is a cutting-edge SocialFi platform that is revolutionizing how content producers interact, network, and make money from their work.
  • OpenGradient — OpenGradient is a leading decentralized AI platform for open-source model hosting, secure inference, agentic reasoning, and application deployment. By developing tooling and a feature-rich platform that makes developing AI workflows both secure and seamless, OpenGradient empowers developers with the ability to build in its ecosystem of intelligentand optimized AI-empowered applications. With native model hosting, permissionless composability, and secure inference execution, OpenGradient also aims to accelerate open-source AI by democratizing model ownership, improving verifiability guarantees, and promoting censorship-resistant model access.Our heterogeneous AI compute architecture (HACA) and our proprietary library NeuroML scale secure AI workflows with features like inference, agentic reasoning, statistical analysis, and more. OpenGradient also accelerates open-source innovation with a web portal and SDK for Web2 developers to leverage our AI stack without navigating blockchain complexities, while enjoying the security and composability benefits of decentralized infrastructure.
Investors by industry
Investors by country
Angel Investors in Europe by industry